Arvest Bank Trust Division’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$308K Sell
2,776
-89,297
-97% -$9.9M 0.02% 161
2025
Q1
$10.3M Sell
92,073
-15,543
-14% -$1.74M 0.65% 51
2024
Q4
$9.94M Sell
107,616
-7,610
-7% -$703K 0.6% 51
2024
Q3
$9.66M Buy
+115,226
New +$9.66M 0.56% 55
2021
Q3
$11.7M Sell
167,130
-4,353
-3% -$304K 0.65% 49
2021
Q2
$11.8M Sell
171,483
-2,300
-1% -$158K 0.65% 49
2021
Q1
$11.2M Sell
173,783
-2,471
-1% -$160K 0.65% 46
2020
Q4
$10.3M Sell
176,254
-2,643
-1% -$154K 0.64% 42
2020
Q3
$11.3M Sell
178,897
-5,591
-3% -$353K 0.81% 39
2020
Q2
$14.2M Buy
184,488
+585
+0.3% +$45K 1.05% 32
2020
Q1
$13.7M Sell
183,903
-21,393
-10% -$1.6M 1.27% 28
2019
Q4
$13.3M Sell
205,296
-5,543
-3% -$360K 0.86% 42
2019
Q3
$13.4M Sell
210,839
-5,823
-3% -$369K 0.92% 39
2019
Q2
$14.6M Sell
216,662
-5,576
-3% -$377K 1% 36
2019
Q1
$14.4M Sell
222,238
-1,608
-0.7% -$105K 1% 36
2018
Q4
$14M Sell
223,846
-263
-0.1% -$16.5K 1.12% 28
2018
Q3
$17.3M Sell
224,109
-3,567
-2% -$275K 1.17% 28
2018
Q2
$16.1M Sell
227,676
-2,022
-0.9% -$143K 1.15% 27
2018
Q1
$17.3M Sell
229,698
-2,388
-1% -$180K 1.23% 25
2017
Q4
$16.6M Sell
232,086
-7,576
-3% -$543K 1.16% 31
2017
Q3
$19.4M Buy
239,662
+1,120
+0.5% +$90.7K 1.38% 20
2017
Q2
$16.9M Buy
238,542
+2,665
+1% +$189K 1.28% 25
2017
Q1
$16M Sell
235,877
-6,117
-3% -$415K 1.26% 24
2016
Q4
$17.3M Sell
241,994
-2,062
-0.8% -$148K 1.39% 20
2016
Q3
$19.3M Sell
244,056
-558
-0.2% -$44.2K 1.6% 16
2016
Q2
$20.4M Buy
244,614
+429
+0.2% +$35.8K 1.75% 15
2016
Q1
$22.4M Buy
244,185
+5,824
+2% +$535K 1.9% 11
2015
Q4
$24.1M Sell
238,361
-1,630
-0.7% -$165K 2.1% 9
2015
Q3
$23.6M Buy
239,991
+5,230
+2% +$514K 2.13% 9
2015
Q2
$27.5M Buy
234,761
+1,611
+0.7% +$189K 2.33% 8
2015
Q1
$22.9M Buy
233,150
+3,125
+1% +$307K 1.96% 11
2014
Q4
$23.1M Buy
230,025
+4,072
+2% +$409K 2.02% 9
2014
Q3
$24.1M Buy
+225,953
New +$24.1M 2.22% 8